Sitagliptin - Safe and Effective Treatment of Diabetes
To the innovative methods of type 2 diabetes treatment, of course, it should be included the preparations ofthe incretin series, in particular dipeptidyl peptidase inhibitors 4. Sitagliptin became the first representative ofdipeptidyl peptidase 4 inhibitors. Sitagliptin has unique pharmacokinetic characteristics for this class of drugs. Its efficacy and safety in theform ofmono- and combination therapy has been confirmed in a number of placebo-controlled studies.